← Clinical Evidence

SRC-3fcb84c73d99 Berger K 2026

Evidence source and scope

A comprehensive assessment of lifecourse and mortality of Parkinson’s disease in the German National Cohort.

This note indexes a cited or audit-added source. It may be an original study, review, guideline, form or methods reference. Treat the specific design and the evidence below as authoritative; a source note is not automatically a primary study.

DOI: 10.1038/s41531-026-01446-0

Bibliographic record from the original reports

Access labels embedded in these original reference strings are historical. Current access and exact checked components are stated separately below.

Berger K, Karch A, Lill CM, Berger TL, Mueller U, Bartl M et al. A comprehensive assessment of lifecourse and mortality of Parkinson’s disease in the German National Cohort. npj Parkinson's Disease. 2026;12(1):156. DOI 10.1038/s41531-026-01446-0

Conditions: COND-PD Parkinson’s disease

Scoped audit evidence

These are source- and component-level audit summaries as of 3 October 2026. Access and comparison scope can differ by report; none certifies every result or the underlying raw data.

Parkinson’s disease — strength

STR-74-01

Limitations: Only current scoped checks; archived captures not authenticated against live originals.

Parkinson’s disease strength

Parkinson’s disease strength component — NAKO mortality exposure

Full statistical methods specify death as outcome and age, sex and algorithm-based PD status as predictors. Grip is a separate functional comparison, not the mortality exposure.

Source locator: Full original Statistical Analysis;Tables 2–3

Limitations: AI-assisted source comparison; no raw-data verification.

Reports citing this source

Update record

Updating the wiki · Evidence and status guide